Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea [Phase 3]

View source ↗

Summary

Phase 3 trial POETYK-PSO-3 evaluating BMS-986165 vs placebo in plaque psoriasis across several Asian regions has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-11-02